1. Home
  2. INVZ vs PBYI Comparison

INVZ vs PBYI Comparison

Compare INVZ & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVZ
  • PBYI
  • Stock Information
  • Founded
  • INVZ 2016
  • PBYI 2010
  • Country
  • INVZ Israel
  • PBYI United States
  • Employees
  • INVZ N/A
  • PBYI N/A
  • Industry
  • INVZ Auto Parts:O.E.M.
  • PBYI Biotechnology: Pharmaceutical Preparations
  • Sector
  • INVZ Consumer Discretionary
  • PBYI Health Care
  • Exchange
  • INVZ Nasdaq
  • PBYI Nasdaq
  • Market Cap
  • INVZ 154.6M
  • PBYI 147.8M
  • IPO Year
  • INVZ N/A
  • PBYI N/A
  • Fundamental
  • Price
  • INVZ $0.57
  • PBYI $2.92
  • Analyst Decision
  • INVZ Strong Buy
  • PBYI Strong Buy
  • Analyst Count
  • INVZ 5
  • PBYI 1
  • Target Price
  • INVZ $3.24
  • PBYI $7.00
  • AVG Volume (30 Days)
  • INVZ 3.3M
  • PBYI 360.5K
  • Earning Date
  • INVZ 05-07-2025
  • PBYI 05-01-2025
  • Dividend Yield
  • INVZ N/A
  • PBYI N/A
  • EPS Growth
  • INVZ N/A
  • PBYI 37.78
  • EPS
  • INVZ N/A
  • PBYI 0.62
  • Revenue
  • INVZ $24,268,000.00
  • PBYI $230,468,000.00
  • Revenue This Year
  • INVZ $135.37
  • PBYI N/A
  • Revenue Next Year
  • INVZ $132.60
  • PBYI N/A
  • P/E Ratio
  • INVZ N/A
  • PBYI $4.70
  • Revenue Growth
  • INVZ 16.25
  • PBYI N/A
  • 52 Week Low
  • INVZ $0.45
  • PBYI $2.23
  • 52 Week High
  • INVZ $3.14
  • PBYI $6.06
  • Technical
  • Relative Strength Index (RSI)
  • INVZ 28.86
  • PBYI 39.35
  • Support Level
  • INVZ $0.59
  • PBYI $3.14
  • Resistance Level
  • INVZ $0.76
  • PBYI $3.18
  • Average True Range (ATR)
  • INVZ 0.05
  • PBYI 0.19
  • MACD
  • INVZ 0.01
  • PBYI -0.06
  • Stochastic Oscillator
  • INVZ 9.57
  • PBYI 10.97

About INVZ Innoviz Technologies Ltd. Ordinary shares

Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks, and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: